• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2020 年 1 月 19 日至 3 月 10 日，韩国 54 例新冠肺炎死亡病例分析。

Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020.

出版信息

J Korean Med Sci. 2020 Mar 30;35(12):e132. doi: 10.3346/jkms.2020.35.e132.

DOI:10.3346/jkms.2020.35.e132
PMID:32233161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7105509/
Abstract

Since the identification of the first case of coronavirus disease 2019 (COVID-19), the global number of confirmed cases as of March 15, 2020, is 156,400, with total death in 5,833 (3.7%) worldwide. Here, we summarize the morality data from February 19 when the first mortality occurred to 0 am, March 10, 2020, in Korea with comparison to other countries. The overall case fatality rate of COVID-19 in Korea was 0.7% as of 0 am, March 10, 2020.

摘要

自 2019 年冠状病毒病（COVID-19）首例病例确诊以来，截至 2020 年 3 月 15 日，全球确诊病例数为 156400 例，全球总死亡人数为 5833 人（3.7%）。在这里，我们总结了从 2020 年 2 月 19 日首次出现死亡病例到 2020 年 3 月 10 日 0 点韩国的死亡数据，并与其他国家进行了比较。截至 2020 年 3 月 10 日 0 点，韩国 COVID-19 的总病死率为 0.7%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/2269ebc11267/jkms-35-e132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/08f57ebf8ce2/jkms-35-e132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/6fed9719f01b/jkms-35-e132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/e0b0d6886265/jkms-35-e132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/60b3913ebb61/jkms-35-e132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/7bb243640bc1/jkms-35-e132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/2269ebc11267/jkms-35-e132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/08f57ebf8ce2/jkms-35-e132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/6fed9719f01b/jkms-35-e132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/e0b0d6886265/jkms-35-e132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/60b3913ebb61/jkms-35-e132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/7bb243640bc1/jkms-35-e132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7105509/2269ebc11267/jkms-35-e132-g006.jpg

相似文献

1
Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020.2020 年 1 月 19 日至 3 月 10 日，韩国 54 例新冠肺炎死亡病例分析。
J Korean Med Sci. 2020 Mar 30;35(12):e132. doi: 10.3346/jkms.2020.35.e132.
2
Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals.国家定点救治医院收治的新冠肺炎患者的临床特征和死亡预测因素。
J Korean Med Sci. 2020 Sep 14;35(36):e328. doi: 10.3346/jkms.2020.35.e328.
3
Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020.2020 年 1 月 19 日至 3 月 2 日韩国 2019 年冠状病毒病（COVID-19）疫情的流行病学特征报告。
J Korean Med Sci. 2020 Mar 16;35(10):e112. doi: 10.3346/jkms.2020.35.e112.
4
Disparities in Age-specific Morbidity and Mortality From SARS-CoV-2 in China and the Republic of Korea.中国和韩国的 SARS-CoV-2 年龄特异性发病率和死亡率的差异。
Clin Infect Dis. 2020 Jul 28;71(15):863-865. doi: 10.1093/cid/ciaa354.
5
Preliminary estimates of the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020.截至 2020 年 3 月 5 日对韩国和意大利冠状病毒病（COVID-19）疫情的基本繁殖数的估计。
Int J Infect Dis. 2020 Jun;95:308-310. doi: 10.1016/j.ijid.2020.04.044. Epub 2020 Apr 22.
6
Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019.2019年冠状病毒病病死率的理解与解读
J Korean Med Sci. 2020 Mar 30;35(12):e137. doi: 10.3346/jkms.2020.35.e137.
7
Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease.从基础疾病角度看韩国新冠肺炎感染死亡率
Disaster Med Public Health Prep. 2020 Jun;14(3):384-386. doi: 10.1017/dmp.2020.60. Epub 2020 Mar 31.
8
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病中度至重度感染合并糖尿病患者的临床特征和结局。
Diabetes Metab J. 2020 Aug;44(4):602-613. doi: 10.4093/dmj.2020.0146. Epub 2020 Aug 12.

引用本文的文献

1
Treatment outcomes and healthcare resource utilization in critically ill COVID-19 patients in Korea: A nationwide multicenter cohort study.韩国危重新冠肺炎患者的治疗结果和医疗资源利用情况：一项全国多中心队列研究。
Medicine (Baltimore). 2024 Nov 15;103(46):e40505. doi: 10.1097/MD.0000000000040505.
2
Clinical outcomes of COVID-19 infection in patients with osteoporosis: a nationwide cohort study in Korea using the common data model.COVID-19 感染患者骨质疏松症的临床结局：韩国使用通用数据模型的全国队列研究。
Sci Rep. 2024 Jul 31;14(1):17738. doi: 10.1038/s41598-024-68356-0.
3
Clinical features, coagulation and inflammatory biomarkers associated with poor in-hospital outcomes in a Honduran population with RT-PCR confirmed COVID-19.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病（COVID-19）疫情的流行病学特征 - 中国，2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020.2020 年 1 月 19 日至 3 月 2 日韩国 2019 年冠状病毒病（COVID-19）疫情的流行病学特征报告。
J Korean Med Sci. 2020 Mar 16;35(10):e112. doi: 10.3346/jkms.2020.35.e112.
在洪都拉斯人群中，经逆转录聚合酶链反应（RT-PCR）确诊的2019冠状病毒病（COVID-19）患者的临床特征、凝血和炎症生物标志物与不良院内结局的相关性
Thromb Update. 2022 Dec;9:100124. doi: 10.1016/j.tru.2022.100124. Epub 2022 Oct 4.
4
Difference in determinants of ICU admission and death among COVID-19 hospitalized patients in two epidemic waves in Portugal: possible impact of healthcare burden and hospital bed occupancy on clinical management and outcomes, March-December 2020.葡萄牙两波 COVID-19 住院患者 ICU 入院和死亡的决定因素差异：医疗负担和病床占用对临床管理和结局的可能影响，2020 年 3 月至 12 月。
Front Public Health. 2023 Jun 29;11:1215833. doi: 10.3389/fpubh.2023.1215833. eCollection 2023.
5
Assessment of the Suitability of the Fleischner Society Imaging Guidelines in Evaluating Chest Radiographs of COVID-19 Patients.评估 Fleischner 学会影像学指南在评估 COVID-19 患者胸部 X 光片的适用性。
J Korean Med Sci. 2023 Jul 3;38(26):e199. doi: 10.3346/jkms.2023.38.e199.
6
Epidemiological Characteristics of Deaths from COVID-19 in Peru during the Initial Pandemic Response.秘鲁在疫情初期应对阶段新冠病毒病死亡病例的流行病学特征
Healthcare (Basel). 2022 Nov 30;10(12):2404. doi: 10.3390/healthcare10122404.
7
A systematic review and meta-analysis of the epidemiological characteristics of COVID-19 in children.一项关于儿童 COVID-19 流行病学特征的系统评价和荟萃分析。
BMC Pediatr. 2022 Oct 22;22(1):613. doi: 10.1186/s12887-022-03624-4.
8
Telehealth Is Not Optional but Essential.远程医疗并非可有可无，而是至关重要。
Int J Heart Fail. 2020 Oct 26;2(4):242-243. doi: 10.36628/ijhf.2020.0038. eCollection 2020 Oct.
9
Clinical characteristics and epidemiological significance of coronavirus disease 2019 in children and adolescents.儿童和青少年 2019 冠状病毒病的临床特征和流行病学意义。
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Aug 15;24(8):846-852. doi: 10.7499/j.issn.1008-8830.2205026.
10
Computer-aided discovery, design, and investigation of COVID-19 therapeutics.新冠病毒治疗药物的计算机辅助发现、设计与研究
Tzu Chi Med J. 2022 Mar 28;34(3):276-286. doi: 10.4103/tcmj.tcmj_318_21. eCollection 2022 Jul-Sep.